GT Biopharma Gross Margin Growth & History (GTBP)

GT Biopharma's gross margin was 100.00% for fiscal 2015.

View full GT Biopharma company overview

GT Biopharma annual gross margin history

GT Biopharma annual gross margin

Fiscal yearPeriod endedGross marginChange (percentage points)
20152015-12-31100.00%+93.44 pp
20142014-12-316.56%−32.03 pp
20132013-12-3138.59%−33.93 pp
20122012-12-3172.51%+157.13 pp
20112011-12-31−84.62%+406.29 pp
20102010-12-31−490.91%

GT Biopharma gross margin trends

Over the last five reported fiscal years, GT Biopharma's gross margin increased from −490.91% to 100.00%, a change of +590.91 percentage points. The latest reported quarter, Q2 2015, shows 100.00%.

About the metric

What gross margin means

Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.

Calculation and source

How gross margin is calculated

TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review GT Biopharma filings at SEC.gov ↗